This may surprise you, as it surprised me
Luo L, Ramanathan R, Horlbogen L, Mathialagan S, Costales C, Vourvahis M, et al
A medication was excluded from the analysis if the brand name was unavailable
Things To Consider Before pursuing participation in the program, it is important to keep several key points in mind: The program is temporary and is scheduled to end on December 31, 2027 Not all beneficiaries will meet eligibility requirements Physician approval and documentation are required before coverage is granted These medications may not be appropriate for everyone and should be used under medical supervision Additionally, because this is a specialized demonstration program, it may operate differently from standard Medicare prescription drug coverage
Visible changes in skin tone typically take several weeks or months of consistent use
Clinical studies have demonstrated that Melanotan-1 can be safely combined with light, acting synergistically to provide a tanning response